GLP-1 Online: Telehealth Routes

Yes. You can get GLP-1 medicines online: a telehealth visit for the prescription, then a mail-order pharmacy. Self-pay starts at $149 a month (NovoCare Pharmacy: Ozempic pill (from 1.5 mg)). WeightWatchers Med+ charges $223 a month all in.

Lowest self-pay: $149 a month
Telehealth from, all in: $223 a month
Prescription: Required
Shortage: Some products short

Weight loss and half-life overview

Time each medicine remains in your body

Section 12.3 of each FDA label lists the half-life in days. That figure shows how long the body takes to clear half a dose.

Weight loss in each medicine's main weight trial

Share of body weight. Because trials use different doses and lengths, check each result against the placebo shown on that medicine's page.

Sources (10)

FDA DailyMed labels: 1 2 3 4 5 6 7 8 9 10.

Every legitimate GLP-1 route, ranked

Ways to get it, cheapest first
Route	Who it is for	What you pay
Ozempic: Novo Nordisk PAP	Federal poverty level: household income of 200% or less	Free if approved
Trulicity: Lilly Cares	Federal poverty level: household income of 300% or less	Free for up to 12 months
Ozempic: Your doctor, with insurance and the savings card	Commercial insurance that covers it	The cost may be as little as $25 each month, for a period of up to 3 months
Wegovy: Your doctor and insurance, with a savings card	Commercial insurance that covers it	As little as $25 a month
Mounjaro: Your doctor, with insurance and the savings card	Commercial insurance that covers it	As little as $25 for a 3-month fill or less
Zepbound: Your doctor and insurance, with a savings card	Commercial insurance that covers it	As little as $25 for a 3-month fill or less
Foundayo: Your doctor and insurance, with a savings card	Commercial insurance that covers it	As little as $25 a month
Rybelsus: Your doctor, with insurance and the savings card	Commercial insurance that covers it	A 1-, 2-, or 3-month fill may cost as little as $25
Trulicity: Your doctor and insurance, with a savings card	Commercial insurance that covers it	As little as $25 for a 3-month fill or less

Prices checked November 2026. Each price links to the page it came from.

Sources: Novo Nordisk pricing, NovoCare, TrumpRx, rx.costco.com.

Who qualifies

Every GLP-1 sold in the US needs a prescription. For an approved use on the label, a prescriber writes it:

Ozempic lowers blood sugar in adults with type 2 diabetes. It is used with diet and exercise.
Ozempic: For adults with type 2 diabetes and heart disease, it lowers the risk of heart attack, stroke, and heart-related death.
Wegovy: In injection and tablet forms, it lowers the risk of heart attack, stroke, and heart-related death for adults with heart disease who have obesity or are overweight.
Wegovy: Adults and children 12 and older with obesity can use it for long-term weight loss and weight maintenance, along with diet and activity. It also applies to overweight adults with a weight-related condition.
Mounjaro lowers blood sugar for adults and children 10 and older with type 2 diabetes. It is taken with diet and exercise.
Mounjaro: For adults with type 2 diabetes who face high risk, it lowers the risk of heart attack, stroke, and heart-related death.
For long-term weight loss and weight maintenance, Zepbound is used with diet and activity by adults with obesity or overweight adults with a weight-related condition.
Zepbound: It treats moderate to severe obstructive sleep apnea in adults with obesity.
For long-term weight loss and weight maintenance, Foundayo is used with diet and activity by adults with obesity or overweight adults with a weight-related condition.
Rybelsus lowers blood sugar in adults with type 2 diabetes. It is used with diet and exercise.
Rybelsus: For high-risk adults with type 2 diabetes, it lowers the risk of heart attack, stroke, and heart-related death.
Trulicity lowers blood sugar for children 10 and older and adults with type 2 diabetes. It is used with diet and exercise.
For adults with type 2 diabetes plus heart disease or several heart risk factors, Trulicity reduces the chance of heart attack, stroke, or heart-related death.
Saxenda: Along with diet and activity, it helps with weight loss and keeping weight off long term. People with obesity aged 12 and older (over 60 kg) can take it. Adults who have overweight and a weight-related condition can take it as well.
For people with type 2 diabetes, Victoza lowers blood sugar. This includes adults and children aged 10 and up.
For adults with type 2 diabetes and heart disease, Victoza lowers the risk of heart attack, stroke, or heart-related death.

Source: FDA label (DailyMed).

Telehealth choices compared

Telehealth programs for GLP-1
Program	Medicine option	Medicine price	Membership	All in
WeightWatchers Med+	Foundayo pill (self-pay)	$149 a month	$74 a month	$223 a month
WeightWatchers Med+	Wegovy pill (self-pay)	$149 a month	$74 a month	$223 a month
WeightWatchers Med+	Ozempic injectable pen (self-pay)	$199 a month	$74 a month	$273 a month
Ro	Wegovy pill, starting dose	$149 a month	$149 a month	$298 a month
Ro	Foundayo pill, starting dose	$149 a month	$149 a month	$298 a month
Hims & Hers	Wegovy pill	$149 a month	$149 a month after first month	$298 a month
Hims & Hers	Ozempic pen	$199 a month	$149 a month after first month	$348 a month
WeightWatchers Med+	Zepbound (self-pay)	$299 a month	$74 a month	$373 a month
Sesame (Success by Sesame)	Wegovy or Ozempic pen, after intro months	$349 a month	$59 a month	$408 a month
Ro	Zepbound KwikPen, starting dose	$299 a month	$149 a month	$448 a month
Ro	Wegovy pen, 1 mg to 2.4 mg	$349 a month	$149 a month	$498 a month
Hims & Hers	Zepbound	$1,899 a month	$149 a month after first month	$2,048 a month
Hims & Hers	Mounjaro	$1,899 a month	$149 a month after first month	$2,048 a month
Mochi Health	Compounded semaglutide (not FDA approved)	$60 a month	$79 a month after free first month	$139 a month
Mochi Health	Compounded tirzepatide (not FDA approved)	$90 a month	$79 a month after free first month	$169 a month
Henry Meds	Compounded liraglutide (daily injection) (not FDA approved)	$179 a month	Not listed	Included
Henry Meds	Tablets or drops for sublingual compounded semaglutide, with no FDA approval	$179 a month	Not listed	Included
Noom Med	Microdose GLP-1Rx Program (compounded) (not FDA approved)	after first 4 weeks, $179 a month, with quarterly billing	Not listed	Included
Noom Med	GLP-1Rx Program (compounded semaglutide) (not FDA approved)	after the first 4 weeks, quarterly bills cover $249 per month	Not listed	Included
Found	Compounded GLP-1 plan (not FDA approved)	$99 a month	$169 a month cash	$268 a month
Henry Meds	Compounded semaglutide (weekly injection) (not FDA approved)	$297 a month	Not listed	Included
Noom Med	Compounded GLP-1 and GIP forms offered through the GLP-1Rx Plus Program, with no FDA approval	after first 4 weeks, $299 a month, with quarterly billing	Not listed	Included

Each program's own pricing page lists the prices. No money comes to us from any of them.

Programs that handle medicine billing through insurance or a pharmacy
Program	Membership	Type
Calibrate	$199 a month	insurance-first
PlushCare	$19.99 a month	primary care membership
Hello Alpha	$79 a month	brand only

Sources: weightwatchers.com, ro.co, hims.com, sesamecare.com.

Shortage status

The injection shortage for semaglutide ended on February 21, 2025. Discontinuation is under way for the older Rybelsus tablets.

Semaglutide supply for each product
Product	FDA status	Availability
Rybelsus tablet 3 mg, 7 mg, 14 mg	To Be Discontinued	Replaced by Ozempic (semaglutide) tablets

March 2022 was its first appearance on the FDA shortage list
Shortage resolved: February 21, 2025
On April 22, 2025, state pharmacies were required to stop producing compounded copies
Outsourcing facilities had to stop as of May 22, 2025

The tirzepatide shortage has ended. On December 19, 2024, the FDA confirmed this.

It first appeared on the FDA shortage list: December 15, 2022
Shortage resolved: December 19, 2024
On February 18, 2025, state pharmacies were required to stop producing compounded copies
Outsourcing facilities had to stop on March 19, 2025

Dulaglutide: According to Lilly, every Trulicity dose is available, and current FDA shortage data does not list it

For Liraglutide, a current shortage is still listed. In January 2027, Saxenda will be discontinued. Availability of Victoza pens is limited now, and generic versions are available.

Supply of liraglutide by product
Product	FDA status	Availability
Victoza 6 mg/mL pen (2-pack and 3-pack)	Current	Limited Availability
Victoza back order	Current	Back order
Saxenda 6 mg/mL pen (5-pack)	To Be Discontinued	Available until January 2027
Generic liraglutide (Meitheal, Teva)	Current	Available

It first appeared on the FDA shortage list: July 18, 2023

Sources: FDA, api.fda.gov, ashp.org.

Scam signals

No prescription needed: a seller who skips this step is not licensed as a US pharmacy.
Brand pricing far below the manufacturer's own rate: the lowest self-pay price is $149 a month.
Marketing a compounded drug as the brand: without FDA approval, these drugs are not Ozempic, Wegovy, Mounjaro or Zepbound
Salt forms vary: approved drugs use an active ingredient that does not match semaglutide sodium or semaglutide acetate
Claiming a product matches the brand: the FDA sent 30 warning letters to telehealth companies over misleading claims.
Harm reports: Compounded semaglutide is tied to 990 adverse event reports the FDA has received.
Compounded tirzepatide: The FDA has received more than 730 adverse event reports related to it.
The FTC acted against one program because its monthly price did not include the drug. For details, read the NextMed review.

Sources: Novo Nordisk pricing, NovoCare, TrumpRx, rx.costco.com.

Find it in your state

Hims & Hers: It does not serve some of the 50 states
Noom Med: It does not serve some of the 50 states
NovoCare Pharmacy: Its delivery network reaches all 50 states, DC, Puerto Rico

The route changes most because of Medicaid rules. GLP-1s for weight loss are covered right now by 10 state Medicaid programs. Choose your state to see its drug list and what prior authorization rules apply:

Sources: hims.com, noom.com, NovoCare.